in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Wacker Adds to Biologics Capacity in Germany
November 7, 2007 | Alex Scott
Wacker Chemie (Munich, Germany) says it will invest €15 million ($22 million) to expand its biopharmaceuticals manufacturing operations at Jena, Germany. The investment program will include two projects; a new manufacturing facility to go online at the end of 2009; and a new building for process development and quality control scheduled for completion in late 2008. “The new facilities will enable us to greatly accelerate our growth in the attractive biologics market,” says Gerhard Schmid, president of Wacker Fine Chemicals, the group’s...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee